R Mertelsmann

2.2k total citations
54 papers, 1.6k citations indexed

About

R Mertelsmann is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, R Mertelsmann has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 19 papers in Hematology and 13 papers in Immunology. Recurrent topics in R Mertelsmann's work include Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Cytokine Signaling Pathways and Interactions (7 papers). R Mertelsmann is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Cytokine Signaling Pathways and Interactions (7 papers). R Mertelsmann collaborates with scholars based in Germany, United States and Netherlands. R Mertelsmann's co-authors include Lothar Kanz, Dietmar Berger, W. A. Dengler, A Lindemann, W. Brugger, S Heimfeld, RJ Berenson, Johannes H. Schulte, H. H. Fiebig and G. Schulz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

R Mertelsmann

51 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Mertelsmann Germany 21 733 506 424 393 199 54 1.6k
MH Freedman Canada 27 846 1.2× 381 0.8× 440 1.0× 582 1.5× 384 1.9× 64 1.9k
A Foti United States 16 375 0.5× 242 0.5× 334 0.8× 501 1.3× 223 1.1× 29 1.4k
Seiji Kojima Japan 20 414 0.6× 213 0.4× 220 0.5× 308 0.8× 175 0.9× 40 1.1k
Ewa Carrier United States 23 375 0.5× 678 1.3× 659 1.6× 671 1.7× 285 1.4× 70 2.0k
Mark A. Guthridge Australia 24 493 0.7× 654 1.3× 797 1.9× 1.2k 3.0× 195 1.0× 47 2.4k
Alexis Grande Italy 25 280 0.4× 310 0.6× 415 1.0× 824 2.1× 101 0.5× 70 1.6k
Jean‐Claude Chomel France 22 774 1.1× 305 0.6× 141 0.3× 672 1.7× 619 3.1× 75 1.8k
Leslie S. Kean United States 30 712 1.0× 448 0.9× 999 2.4× 489 1.2× 319 1.6× 104 2.2k
Robert S. Welner United States 27 767 1.0× 328 0.6× 1.0k 2.5× 861 2.2× 252 1.3× 85 2.2k
Bertil Casslén Sweden 26 322 0.4× 229 0.5× 462 1.1× 353 0.9× 230 1.2× 66 1.6k

Countries citing papers authored by R Mertelsmann

Since Specialization
Citations

This map shows the geographic impact of R Mertelsmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Mertelsmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Mertelsmann more than expected).

Fields of papers citing papers by R Mertelsmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Mertelsmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Mertelsmann. The network helps show where R Mertelsmann may publish in the future.

Co-authorship network of co-authors of R Mertelsmann

This figure shows the co-authorship network connecting the top 25 collaborators of R Mertelsmann. A scholar is included among the top collaborators of R Mertelsmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Mertelsmann. R Mertelsmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Lei, E. Tánczos, Jürgen Kopp, et al.. (1997). Paracrine stimulation of keratinocytes in vitro and continuous delivery of epidermal growth factor to wounds in vivo by genetically modified fibroblasts transfected with a novel chimeric construct.. PubMed. 11(3). 201–8. 16 indexed citations
2.
Tamm, Ingo, Elisabeth Bergen, Erwin Schöpf, et al.. (1997). Dacarbazine and Interferon Alpha for Stage IV Malignant Melanoma. Oncology. 54(4). 270–274. 5 indexed citations
3.
Ochs, A., Dietmar Berger, R Mertelsmann, et al.. (1997). The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients. Annals of Oncology. 8(2). 200–202. 17 indexed citations
4.
Otto, F, Peter Schmid, Andréas Mackensen, et al.. (1996). Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer. European Journal of Cancer. 32(10). 1712–1718. 82 indexed citations
5.
Primrose, John, et al.. (1996). Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancer. British Journal of Cancer. 74(12). 2018–2023. 4 indexed citations
6.
Mertelsmann, R, A. Lindemann, Thomas Boehm, et al.. (1995). Pilot study for the evaluation of T-cell-mediated tumor immunotherapy by cytokine gene transfer in patients with malignant tumors. Journal of Molecular Medicine. 73(4). 205–6. 10 indexed citations
7.
Dengler, W. A., Johannes H. Schulte, Dietmar Berger, R Mertelsmann, & H. H. Fiebig. (1995). Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Anti-Cancer Drugs. 6(4). 522–532. 219 indexed citations
8.
Berger, Dietmar, et al.. (1995). Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies. Annals of Oncology. 6(8). 817–825. 75 indexed citations
9.
Ganser, Arnold, Oliver G. Ottmann, G. Seipelt, et al.. (1993). Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromes.. PubMed. 7(5). 696–701. 35 indexed citations
10.
Finke, Jürgen, Philipp Ternes, W. Lange, R Mertelsmann, & Gottfried Dölken. (1993). Expression of interleukin 10 in B lymphocytes of different origin.. PubMed. 7(11). 1852–7. 26 indexed citations
11.
Brach, MA, HJ Gruss, D Riedel, R Mertelsmann, & F. Herrmann. (1992). Activation of NF-kappa B by interleukin 2 in human blood monocytes.. PubMed. 3(7). 421–7. 14 indexed citations
12.
Jonas, Daniel E, M Lübbert, Michael Henke, et al.. (1992). Clonal analysis of bcr-abl rearrangement in T lymphocytes from patients with chronic myelogenous leukemia. Blood. 79(4). 1017–1023. 47 indexed citations
13.
Herrmann, F. & R Mertelsmann. (1992). Regulatory effects of cytokines on myelopoiesis.. PubMed. 57. 339–49. 1 indexed citations
14.
Kanz, Lothar, A. Lindemann, Wolfgang Oster, F. Herrmann, & R Mertelsmann. (1991). Hemopoietins in Clinical Oncology. American Journal of Clinical Oncology. 14. S27–33. 7 indexed citations
15.
Lindemann, A, et al.. (1991). Screening for expression of cytokines with hematopoietic growth factor activity by permanent human B-cell lines.. PubMed. 5(8). 715–8. 8 indexed citations
16.
Herrmann, François R., Wolfgang Oster, & R Mertelsmann. (1990). Control of blast cell proliferation and differentiation in acute myelogenous leukemia by soluble polypeptide growth factors. Klinische Pädiatrie. 202(4). 212–217. 2 indexed citations
17.
Lindemann, A, et al.. (1989). Monokines: stimulatory and inhibitory regulator molecules of myelopoiesis in vitro.. PubMed. 2(3). 134–8. 7 indexed citations
18.
Herrmann, F., A. Lindemann, H Klein, et al.. (1989). Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts.. PubMed. 3(5). 335–8. 78 indexed citations
19.
Herrmann, F., et al.. (1988). Yeast-expressed granulocyte-macrophage colony-stimulating factor in cancer patients: a phase ib clinical study.. PubMed. 107–18. 11 indexed citations
20.
Oster, Wolfgang, A Lindemann, R Mertelsmann, & F. Herrmann. (1988). Regulation of gene expression of M-, G-, GM-, and multi-CSF in normal and malignant hematopoietic cells.. PubMed. 14(2-3). 443–62. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026